Lydie Meheus

Title: Lydie Meheus: Innovator in Immunology

Introduction

Lydie Meheus is a notable inventor based in Merelbeke, Belgium. She has made significant contributions to the field of immunology, particularly in the diagnosis and treatment of systemic lupus erythematosus.

Latest Patents

Lydie Meheus holds a patent for "Methylated, SMD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus." This invention relates to a method of producing specific peptides that contain methylated arginines followed by a glycine residue. These peptides serve as immunogenic determinants of antibodies present in the sera of patients with systemic lupus erythematosus or Epstein-Barr virus. The methylation of these peptides is crucial for their reactivity with the antibodies. Furthermore, the invention outlines the use of these peptides for diagnosing and treating systemic lupus erythematosus and related diseases.

Career Highlights

Lydie Meheus is associated with Innogenetics N.V., where she has been instrumental in advancing research in immunology. Her work has led to innovative solutions that address critical health issues.

Collaborations

Lydie collaborates with notable colleagues, including Ann Union and Joseph Raymackers, who contribute to her research endeavors.

Conclusion

Lydie Meheus is a pioneering inventor whose work in immunology has the potential to significantly impact the diagnosis and treatment of systemic lupus erythematosus. Her contributions exemplify the importance of innovation in addressing complex health challenges.